August 2, 2012 · STOCK Act disclosure
Representative James B. Renacci (Republican-OH) sold Alexion Pharmaceuticals, Inc., a stock transaction, valued at $1,757.78. The trade took place on August 2, 2012 and was disclosed on May 15, 2013 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.